Infusions of casein hydrolyzates into the mammary gland disrupt tight junction integrity and induce involution in cows.
Milk stasis triggers local stimuli, which make the tight junctions leak and trigger involution. The aim of the study was to test the hypothesis that casein hydrolyzates compromise tight junction integrity and dry-off milk secretion in dairy cows. Six repeated doses of casein hydrolyzates after each milking during 3 d caused drastic changes in mammary secretion and composition, which were associated with irreversible cessation of milk secretion. No such changes were recorded in the control glands that had been treated with nonhydrolyzed casein. Treatment with casein hydrolyzates disturbed tight junction integrity within 8 h (as indicated by changes in Na+ and K+ concentrations), reduced the concentrations of lactose precipitously, activated the plasmin activator-plasminogen-plasmin system, and induced the secretion of immunoglobulin type G and lactoferrin. At the end of the 3-d treatments, we stopped milking the experimental and control glands. Milk composition 19 d later was similar in the experimental and control glands and was consistent with the composition expected in fully involuted glands. We conclude that casein hydrolyzates are among the milk-borne factors that cause the disruption of tight junction integrity and induce involution in cows. The process induced by casein hydrolyzate was more rapid and synchronized than the involution induced at drying-off.
Shamay
A
A
Agricultural Research Organization, the Volcani Center, Institute of Animal Science, P.O. Box 6, Bet Dagan, 50250 Israel.
Shapiro
F
F
Leitner
G
G
Silanikove
N
N
D000418:Albumins / Q000032:analysis; D000818:Animals; D002364:Caseins / Q000008:administration & dosage* / Q000032:analysis; D002417:Cattle / Q000502:physiology*; D005260:Female; D005341:Fibrinolysin / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007774:Lactation; D007781:Lactoferrin / Q000032:analysis; D007785:Lactose / Q000032:analysis; D008321:Mammary Glands, Animal / Q000737:chemistry / Q000187:drug effects* / Q000648:ultrastructure*; D008892:Milk / Q000737:chemistry / Q000166:cytology / Q000378:metabolism*; D008894:Milk Proteins / Q000032:analysis; D008903:Minerals / Q000032:analysis; D010958:Plasminogen / Q000032:analysis; D010960:Plasminogen Activators / Q000032:analysis; D011188:Potassium / Q000032:analysis; D011247:Pregnancy; D011492:Protein Hydrolysates / Q000008:administration & dosage*; D011506:Proteins / Q000032:analysis; D012964:Sodium / Q000032:analysis; D019108:Tight Junctions / Q000187:drug effects*; D000067816:Whey Proteins
D000418:Albumins; D002364:Caseins; D007074:Immunoglobulin G; D008894:Milk Proteins; D008903:Minerals; D011492:Protein Hydrolysates; D011506:Proteins; D000067816:Whey Proteins; C026375:trypticase-soy broth; D010958:Plasminogen; D012964:Sodium; D007781:Lactoferrin; D010960:Plasminogen Activators; D005341:Fibrinolysin; D007785:Lactose; D011188:Potassium